Morningstar lowers our fair value estimate for Megaport by 16% after mispricing leads to a downgrade in capital allocation ...

ASX set to open higher, after US stocks ended higher, with the Dow Industrials and the S&P 500 closing at record levels, ...

Santos continues to trade at a valuation that implies no growth in the years ahead. Our analyst Mark Taylor thinks that is ...

The Australian share market has crept higher to close at its highest ever on a day that also saw a $5 billion acquisition in the goldmining industry. The benchmark S&P/ASX200 index on Monday rose 11.7 ...

Joseph explored everything from investing systems to reader questions and one Uber driver's plan to turn his side hustle into ...

Dimensional Global Value Trust DGVA is based on DFA's trademark multifactor methodology and remains a fine pick within ...

Narrow-moat Fisher & Paykel’s FPH first-half fiscal 2025 revenue grew strongly, up 17% to NZD 951 million, while net profit ...

This webinar series is designed to provide all the information you need to build a portfolio that generates consistent and growing income. The Big Four banks have had an extraordinary run and it’s ...

Financial literacy may be lacking in Australia but one group of year 12 students are attempting to solve for a scenario that ...

This week's chart of the week looks at which markets we expect to achieve double-digit returns over the next decade.

In commodity markets, Brent crude oil was down 0.4% to US$72.70 a barrel, while gold was up 0.3% to US$2,633.29. The ...

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver ...